Be a part of 2nd International Conference on Pain Management

Personalized Pain Management:
Explore how genetics, psychology, and patient profiling are shaping individualized treatment plans. Discover precision-based care that enhances outcomes.

• Pharmacogenomics
• Patient Stratification
• Lifestyle Medicine

Neuromodulation & Spinal Cord Stimulation:
Delve into the latest in implantable devices and neurotechnologies that modulate pain pathways. Learn case-based applications for chronic pain conditions.

• SCS Advances
• DRG Stimulation
• Peripheral Nerve Stimulation

Opioid Alternatives: Multimodal Approaches:
Examine integrative, non-opioid strategies that reduce reliance on narcotics. Focus on combining pharmacologic and non-pharmacologic treatments.

• NSAIDs & Adjuvants
• Physical Therapy
• Complementary Therapies

Regenerative Medicine in Pain Management:
Uncover the science and applications of stem cells, PRP, and biologics in healing damaged tissues. A look at evidence, techniques, and future prospects.

• Orthobiologics
• Sports Injuries
• Spine & Joint Pain

AI and Digital Health in Pain Care:
Learn how artificial intelligence, remote monitoring, and mobile health are transforming pain assessment and decision-making.

• Predictive Analytics
• Pain Apps
• Wearables

Interventional Pain Procedures: What’s New?
Review cutting-edge procedural techniques that offer targeted, image-guided relief for chronic pain.

• Nerve Blocks
• RFA
• Ultrasound-Guided Injections

Chronic Low Back Pain: Latest Guidelines:
Get up to speed with new clinical guidelines and minimally invasive solutions for the most prevalent pain condition.

• Facet Joint Pain
• Discogenic Pain
• Functional Rehab

Psychological Interventions for Chronic Pain:
Explore the role of behavioral therapies and mind-body techniques in improving pain outcomes and patient coping.

• CBT
• ACT
• Biofeedback, Mindfulness

Pain in Cancer Survivors:
Address complex post-treatment pain syndromes and strategies for long-term survivorship care.

• Neuropathic Pain
• Chemotherapy-Induced Pain
• Survivorship Programs

Pediatric Pain Management:
Highlight best practices for assessing and treating pain in infants, children, and adolescents with acute or chronic conditions.

• Procedural Pain
• Chronic Pediatric Pain
• Family-Centered Care

Pain and Sleep: The Vicious Cycle:
Understand how chronic pain disrupts sleep and vice versa, and explore treatment strategies to break the cycle.

• Insomnia Management
• Pharmacotherapy
• Behavioral Sleep Interventions

Cultural Competency in Pain Assessment and Treatment:
Recognize the role of culture, bias, and communication in equitable pain management.

• Health Disparities
• Pain Perception
• Inclusive Care Models

Ketamine and Psychedelics in Pain Medicine:
Review emerging evidence on ketamine and other novel agents as breakthrough treatments for refractory pain.

• CRPS
• Depression-Linked Pain
• Intravenous & Oral Therapies

Fibromyalgia and Central Sensitization Syndromes:
Investigate the neurobiology of widespread pain and multidisciplinary tools to manage sensitization syndromes.

• Functional Pain
• Exercise Therapy
• Neuroplasticity

Workplace Injury & Pain Rehabilitation:
Discuss strategies to manage pain post-injury and support functional recovery and return to work.

• Occupational Health
• Functional Restoration Programs
• Ergonomics

The global pain management drugs market size was valued at $72.6 billion in 2023, and is projected to reach $109.6 billion by 2033, growing at a CAGR of 4.2% from 2024 to 2033. The pain management drugs market is driven by aging global population prone to chronic conditions, technological advancements in drug delivery systems and formulations, and regulatory support for innovative pain therapies drives market expansion.

The global pain management market is poised for significant growth in 2025, driven by rising incidences of chronic pain conditions such as arthritis, neuropathy, cancer pain, and post-surgical pain. With an aging population and increasing awareness about pain as a treatable medical condition, demand for both pharmacological and non-pharmacological treatments is expanding. Technological advancements such as neuromodulation devices, AI-driven diagnostics, and regenerative therapies are reshaping clinical approaches, while regulatory pressures and the opioid crisis are accelerating a shift toward multimodal and non-opioid alternatives.